Literature DB >> 16965430

Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.

A Juzeniene1, P Juzenas, L-W Ma, V Iani, J Moan.   

Abstract

BACKGROUND: 5-Aminolaevulinic acid (ALA) and its ester derivatives are used in photodynamic therapy. Despite extensive investigations, the differences in biodistribution and pharmacokinetics of protoporphyrin IX (PpIX) induced by ALA and its derivatives are still not well understood, notably for humans.
OBJECTIVES: To study porphyrin accumulation after topical application of ALA and two of its ester derivatives in normal human skin.
METHODS: Creams containing 0.2%, 2% and 20% (w/w) of ALA, methyl 5-aminolaevulinate (MAL) and hexyl 5-aminolaevulinate (HAL) were applied on normal human skin of six volunteers. The amount and distribution of porphyrins formed in the skin was investigated noninvasively by means of fluorescence spectroscopy.
RESULTS: Fluorescence emission and excitation spectra exhibited similar spectral shapes for the all drugs, indicating that mainly PpIX was formed. Low concentrations (0.2% and 2%) of MAL induced considerably less PpIX in normal human skin than similar concentrations of ALA and HAL. A high concentration (20%) of ALA gave higher PpIX fluorescence in normal human skin than was found for MAL and HAL.
CONCLUSIONS: The concentrations inducing half of the maximal PpIX fluorescence are around 2% for ALA, 8% for MAL and 1% for HAL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965430     DOI: 10.1111/j.1365-2133.2006.07484.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Beyond the margins: real-time detection of cancer using targeted fluorophores.

Authors:  Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 3.  Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.

Authors:  Christine B Warren; Laszlo J Karai; Allison Vidimos; Edward V Maytin
Journal:  J Am Acad Dermatol       Date:  2009-12       Impact factor: 11.527

4.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

5.  In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy.

Authors:  Hans-Joachim Laubach; Sung K Chang; Seonkyung Lee; Imran Rizvi; David Zurakowski; Steven J Davis; Charles R Taylor; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2008 Sep-Oct       Impact factor: 3.170

6.  Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions.

Authors:  Li-Wen Zhang; Saleh A Al-Suwayeh; Chi-Feng Hung; Chih-Chieh Chen; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2011-04-05

Review 7.  Recent Developments of ICG-Guided Sentinel Lymph Node Mapping in Oral Cancer.

Authors:  Ji-Hoon Kim; Minhee Ku; Jaemoon Yang; Hyung Kwon Byeon
Journal:  Diagnostics (Basel)       Date:  2021-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.